Liposomes in the formulation, on the other hand, may increase the quantity of stylopine delivered directly into cancer cells by receptor-mediated endocytosis (Alshehri et al., 2018; Xiang et al., 2018), interfering with VEGFR2 protein expression as well as triggered apoptosis. This evidence concerns the gene KDR and cancer.